| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $3.17 ▲ +1.50% | Yesterday | $3.10 ▼ -0.63% | Tomorrow's C4 Therapeutics Inc. Common Stock (CCCC) setup is anchored to $3.12 and targets $3.17 (+1.50%). The near-term read is upside; watch $3.21 / $3.03 because daily realized volatility is about 7.75%. |
Tomorrow's C4 Therapeutics Inc. Common Stock (CCCC) setup is anchored to $3.12 and targets $3.17 (+1.50%). The near-term read is upside; watch $3.21 / $3.03 because daily realized volatility is about 7.75%. | ||||
| Week | $3.27 ▲ +4.67% | Last Week | $3.06 ▼ -1.96% | The 7-day C4 Therapeutics Inc. Common Stock model moves from $3.06 to $3.27 (+4.67%). It gives upside momentum context for this stock, so breaks around $3.21 / $3.03 matter more than a single tick. |
The 7-day C4 Therapeutics Inc. Common Stock model moves from $3.06 to $3.27 (+4.67%). It gives upside momentum context for this stock, so breaks around $3.21 / $3.03 matter more than a single tick. | ||||
| Month | $3.43 ▲ +9.96% | Last Month | $2.99 ▼ -4.18% | The 1-month C4 Therapeutics Inc. Common Stock target is $3.43 (+9.96%), compared with the live reference near $3.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month C4 Therapeutics Inc. Common Stock target is $3.43 (+9.96%), compared with the live reference near $3.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $3.68 ▲ +17.87% | Last Year | $2.89 ▼ -7.51% | The 1-year C4 Therapeutics Inc. Common Stock scenario points to $3.68 (+17.87%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year C4 Therapeutics Inc. Common Stock scenario points to $3.68 (+17.87%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $4.26 ▲ +36.43% | 5 Years Ago | $2.64 ▼ -15.30% | The 5-year C4 Therapeutics Inc. Common Stock view is $4.26 (+36.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year C4 Therapeutics Inc. Common Stock view is $4.26 (+36.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $3.12 | Mid |
| Daily Change | +4.35% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 67% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $3.12 | Daily Change | +4.35% |
| Market Cap | $304.44M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.